The Phase 2b OPTIONS trial 536 obese subjects, randomized to receive 0.25, 0.5, or 1 mg/day oral AOD-9604 or placebo over 24 weeks failed to demonstrate statistically significant weight loss at any dose tested
The misreading Id most want to head off is people treating this as an FDA seal of approval, Ash says
Pentadeca Arginate (PDA) is a synthetic peptide made up of 15 amino acids , similar to BPC 157 but it has arginine added in, which gives it extra stability and a longer-lasting effect
Inge geschreven opmerkingen bij de vorige versie van deze website : geschreven opmerkingen bij de vorige versie van deze website : 17 Responses to Home Peter P says: Prachtig werk Dirk
the BPC peptide salts of the present invention are useful for the treatment of hypertension, angina, impotence, circulatory shock, septic shock, stroke, inflammation, respiratory distress syndromes, pulmonary hypertension, pancreatitis, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, and Parkinson's disease
Another major area of interest surrounding BPC 157 involves gastrointestinal signalling and mucosal protection